Skip to main
ICVX
ICVX logo

Icosavax (ICVX)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Icosavax (ICVX) Stock

About Icosavax (ICVX)

Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults. The company was founded by Neil King and David Baker on November 1, 2017 and is headquartered in Seattle, WA.
Market cap$766.86M
Today's volume
Revenue (TTM)
Avg. daily volume1.14M
EBITDA (TTM)
Open
Price / earnings ratio-6.89x
Today's range
Debt / equity
52 week range$4.75 - $16.11
5 year debt / equity37.58x
Beta (LTM)0.8x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsNov 14, 2023
Dividend payable date

Frequently Asked Questions (FAQ)

As of Dec 04, 2025, the market cap for Icosavax stock is $766.86M

The current P/E ratio for Icosavax stock is -6.89

The 52-week high for Icosavax stock is $16.11. The current Icosavax stock price $undefined is 100.00% below its 52-week high

The 52-week low for Icosavax stock is $4.75. The current Icosavax stock price $undefined has increased 100.00% from its 52-week low

No, the Icosavax stock does not pay dividends to its shareholders

How to buy Icosavax stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in Icosavax stock

    Navigate to the Explore page. Then, type Icosavax into the search bar. When you see Icosavax stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased Icosavax stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Icosavax Stock Earnings

The value each ICVX share was expected to gain vs. the value that each ICVX share actually gained.

Icosavax (ICVX) reported Q3 2023 earnings per share (EPS) of -$0.44, beating estimates of -$0.57 by 22.81%. In the same quarter last year, Icosavax's earnings per share (EPS) was -$0.55. Icosavax is expected to release next earnings on 11/14/2023, with an earnings per share (EPS) estimate of $0.

Buy Icosavax (ICVX) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.